A human obesity-associated MC4R mutation with defective Gq/11α signaling leads to hyperphagia in mice
Peter J. Metzger, Aileen Zhang, Bradley A. Carlson, Hui Sun, Zhenzhong Cui, Yongqi Li, Marshal T. Jahnke, Daniel R. Layton, Meenakshi B. Gupta, Naili Liu, Evi Kostenis, Oksana Gavrilova, Min Chen, Lee S. Weinstein
Peter J. Metzger, Aileen Zhang, Bradley A. Carlson, Hui Sun, Zhenzhong Cui, Yongqi Li, Marshal T. Jahnke, Daniel R. Layton, Meenakshi B. Gupta, Naili Liu, Evi Kostenis, Oksana Gavrilova, Min Chen, Lee S. Weinstein
View: Text | PDF
Research Article Metabolism

A human obesity-associated MC4R mutation with defective Gq/11α signaling leads to hyperphagia in mice

Abstract

Melanocortin 4 receptor (MC4R) mutations are the most common cause of human monogenic obesity and are associated with hyperphagia and increased linear growth. While MC4R is known to activate Gsα/cAMP signaling, a substantial proportion of obesity-associated MC4R mutations do not affect MC4R/Gsα signaling. To further explore the role of specific MC4R signaling pathways in the regulation of energy balance, we examined the signaling properties of one such mutant, MC4R (F51L), as well as the metabolic consequences of MC4RF51L mutation in mice. The MC4RF51L mutation produced a specific defect in MC4R/Gq/11α signaling and led to obesity, hyperphagia, and increased linear growth in mice. The ability of a melanocortin agonist to acutely inhibit food intake when delivered to the paraventricular nucleus (PVN) was lost in MC4RF51L mice, as well as in WT mice in which a specific Gq/11α inhibitor was delivered to the PVN; this provided evidence that a Gsα-independent signaling pathway, namely Gq/11α, significantly contributes to the actions of MC4R on food intake and linear growth. These results suggest that a biased MC4R agonist that primarily activates Gq/11α may be a potential agent to treat obesity with limited untoward cardiovascular and other side effects.

Authors

Peter J. Metzger, Aileen Zhang, Bradley A. Carlson, Hui Sun, Zhenzhong Cui, Yongqi Li, Marshal T. Jahnke, Daniel R. Layton, Meenakshi B. Gupta, Naili Liu, Evi Kostenis, Oksana Gavrilova, Min Chen, Lee S. Weinstein

×

Figure 4

Glucose metabolism in MC4RF51L mice.

Options: View larger image (or click on image) Download as PowerPoint
Glucose metabolism in MC4RF51L mice. (A–C) Glucose metabolism in 6- to 7...
(A–C) Glucose metabolism in 6- to 7-month-old male MC4RF51L and WT mice (n = 8–11/group). Glucose tolerance test with AUC shown on the right (A), fasting glucose levels (B), and body weights at the time of glucose tolerance tests (C). (D–F) Glucose metabolism in 6- to 7-month-old female MC4RF51L and WT mice (n = 4–7/group). Glucose tolerance test with AUC shown to the right (D), fasting glucose levels (E), and body weights at the time of glucose tolerance tests (F). (G–I) Glucose metabolism in 4- to 5-week-old female MC4RF51L and WT mice (n = 7/group). Glucose tolerance test with AUC shown on the right (G), fasting glucose levels, (H) and body weights at the time of glucose tolerance tests (I). Data represent mean ± SEM. *P < 0.05, **P < 0.01 vs. WT by unpaired t tests.